From October 27, 2023 to December 31, 2023, the company has repurchased 1,814,653 shares, representing 3.1% for $49.99 million. With this, the company has completed the repurchase of 1,814,653 shares, representing 3.1% for $49.99 million under the buyback announced on October 31, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.14 USD | -3.64% | -4.53% | -6.69% |
Apr. 30 | Harmony Biosciences Acquires Epygenix Therapeutics; Shares Rise | MT |
Apr. 30 | Transcript : Harmony Biosciences Holdings, Inc., Q1 2024 Earnings Call, Apr 30, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.69% | 1.71B | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- HRMY Stock
- News Harmony Biosciences Holdings, Inc.
- Tranche Update on Harmony Biosciences Holdings, Inc.'s Equity Buyback Plan announced on October 31, 2023.